Lymphomas
A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated B-Cell Lymphoma Intolerant of Prior Treatment with Ibrutinib and/or Acalabrutinib (BGB-3111-215)
- Details
ClinicalTrials.gov ID:
NCT04116437
Diagnosis Type:
NA
USOR Number:
- Address
4700 E Hale Parkway, Suite 400
Denver, CO 80220
P: (303) 321-0302